Navigation Links
Study on origin of mutation that causes fatal familiar insomnia
Date:1/7/2009

disease, the European Union launched systems for monitoring the prionic group of illnesses the group to which FFI belongs. It was only then that the high rate of carriers of the mutation (D178N) responsible for FFI was detected in the Basque Country Autonomous Community (with 50% of all cases registered in Spain).

The area is characterised by its mountainous orography, and which has favoured cultural and genetic isolation. These features caused researchers to think that there might be a 'founder effect' of the mutation in the Basque Country 'founder effect' is when a new population of individuals is formed from a very small number, with a large proportion thereof carrying the same genetic characteristics.

Given this situation, three targets were set: to look for the possible founder effect of the D178N mutation amongst patients in the Basque Country; establish relations between carriers in the Basque Country with other cases in Spain and Europe; and fix the historical time of the most recent common ancestor.

Same genetic families

After studying cases of FFI in the Basque Country, the researcher observed that genetic families amongst the patients coincided with each other. She concluded, thus, that the high rate of the disorder is due to a 'founder effect' of the mutation in this geographical area. Moreover, genealogical data link most of the cases and fix the oldest mutation carrier generations in an area in the south of the Basque Country in the XVII and XVIII centuries.

In comparison with other regions, Dr. Rodrguez concluded that links can be established between cases in Germany and those of the Italian Veneto region, on the one hand; between Italians of Tuscany and some Spanish cases, on the other; and that not all Spanish cases have the same origin. On estimating the age of the most recent common ancestor, they were able to calculate that two of these variants of the mutation arose over 2,000 years ago.


'/>"/>
Contact: Press Office
lucia@elhuyar.com
Elhuyar Fundazioa
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study helps explain connection between sleep apnea, stroke and death
2. Methods for studying DNA repair and protein modification are featured in CSH Protocols
3. California study shows shade trees reduce summertime electricity use
4. Study links molecule to muscle maturation, muscle cancer
5. Study shows competition, not climate change, led to Neanderthal extinction
6. Facial expressions of emotion are innate, not learned, says new study
7. Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests
8. Study first to pinpoint why analgesic drugs may be less potent in females than in males
9. Study links ecosystem changes in temperate lakes to climate warming
10. New edition of laboratory manual includes cutting-edge techniques to study gene regulation
11. TGen, Scottsdale Healthcare, Mayo Clinic study new drug to stimulate immune system of cancer victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2014)... 2014 -- Using corn crop residue to make ethanol ... more greenhouse gases than gasoline, according to a study ... . , The findings by a University of Nebraska-Lincoln ... can be used to meet federal mandates to ramp ... Corn stover -- the stalks, leaves and cobs in ...
(Date:4/18/2014)... while feeding a world population predicted to reach ... approach to conservation that considers human-altered landscapes such ... and the natural habitat that supports it might ... where at least three-quarters of the land surface ... is vulnerable to human-caused impacts such as climate ...
(Date:4/18/2014)... they,re planted may be good news for a garden. But ... a plant whose seeds sprouted at the first ,warm spell ... insurance policy against late frosts or unexpected dry spells, it ... Plants whose seeds put off sprouting until conditions are more ... of researchers working at the National Evolutionary Synthesis Center in ...
Breaking Biology News(10 mins):Study casts doubt on climate benefit of biofuels from corn residue 2Study casts doubt on climate benefit of biofuels from corn residue 3Stanford researchers rethink 'natural' habitat for wildlife 2Stanford researchers rethink 'natural' habitat for wildlife 3Stanford researchers rethink 'natural' habitat for wildlife 4Plants with dormant seeds give rise to more species 2
... time in the developing mind, Daniel Casasanto of the ... and colleagues at the Aristotle University of Thessaloniki and ... along parallel paths for different distances or durations. The ... each race, reporting which animal went for a longer ...
... executed two license agreements with SuperPower, a wholly-owned ... the intellectual property on second generation (2G) high ... the Sponsored Research Agreement (SRA) previously executed between ... led by Venkat Selvamanickam, M.D. Anderson chair professor ...
... March 31, 2010 Mariam El-Ashmawy, a student ... Training Program, has been awarded a 2010 Gilliam Fellowship ... (HHMI). Ms. El-Ashmawy, a Lewisville native, is one ... selected this year from institutions across the country. Each ...
Cached Biology News:Children use space to think about time 2SuperPower and UH sign high temperature superconducting wire license agreements 2UT Southwestern student receives fellowship from Howard Hughes Medical Institute 2
(Date:1/15/2014)... 15, 2014 The Pittcon Organizing Committee is ... Food Safety Tech , an e-Journal and producer of ... for the second year for the co-location of Food Labs ... partnership provides that the registration fee to attend the two-day ...
(Date:1/15/2014)... January 15, 2014 Look inside the ... items for the lab, from fluid handling to instruments ... to ship when you order. , Preferred Solutions ... , from the L/S® model for precise flow control ...
(Date:1/15/2014)... England and SAN JOSE, California ... international biotechnology company developing antibody-drug conjugates for cancer, today announced ... Board of Directors. Dr Reynolds has over 20 years, development ... Medical Officer at Seattle Genetics. "I am delighted ...
(Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2
... Md., Sept. 13 Total Site Solutions,(TSS), a ... who provides,comprehensive services for the planning, design and ... in the,pharmaceutical and biotech industry has awarded them ... Project. TSS originally performed technology consulting services ...
... Sept. 13 Southern Research,Institute today announced that ... as SR9025, to Virium Pharmaceuticals, Inc. To date, ... approval and are on,the market. Six others, including ... early clinical trials. (Photo: http://www.newscom.com/cgi-bin/prnh/20070913/DCTH022 ...
... Allos,Therapeutics, Inc. (Nasdaq: ALTH ), a biopharmaceutical ... molecule therapeutics for,the treatment of cancer, today announced ... a corporate overview at the 2007 UBS Global ... presentation will take place at 3:30 p.m. (Eastern) ...
Cached Biology Technology:Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project 2Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project 3Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals 2Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference 2